Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Dementia01:30

Dementia

687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
687
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Comparison of baseline outcomes between surgical and nonoperative management in youth with lower extremity torsional abnormalities" [J Orthopedics 73 (2026) 227-233].

Journal of orthopaedics·2026
Same author

Corrigendum to "Assessments and interventions in individuals with lower extremity torsional abnormality: A scoping review" [J Orthopedics 73 (2026) 247-261].

Journal of orthopaedics·2026
Same author

Assessments and interventions in individuals with lower extremity torsional abnormality: A scoping review.

Journal of orthopaedics·2026
Same author

Comparison of baseline outcomes between surgical and nonoperative management in youth with lower extremity torsional abnormalities.

Journal of orthopaedics·2026
Same author

Digital platforms to facilitate physical activities for people with physical or sensory disabilities: A scoping review.

Disability and health journal·2024
Same author

Automatic detection of skate strokes in short-track speed skating using one single IMU: validation of a new method.

Sports biomechanics·2024

Related Experiment Video

Updated: May 3, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

36.6K

Differential classification of dementia.

E Mohr1, P Brouwers1, J J Claus1

  • 1SCO Hospitals, Elisabeth Bruyere Health Center, Rm 298-20, 75 Bruyere St, Ottawa, Ontario, Canada K1N 5C8.

Behavioural Neurology
|February 4, 2014
PubMed
Summary
This summary is machine-generated.

This study developed a statistical method using neuropsychological tests to accurately classify dementia and differentiate between Alzheimer's and Huntington's diseases. The approach also identified dementia in Parkinson's disease patients.

Keywords:
Cortical and subcortical dementiaDementia classificationDiscriminant analysisNeuropsychological measures

More Related Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.1K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

13.9K

Related Experiment Videos

Last Updated: May 3, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

36.6K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.1K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

13.9K

Area of Science:

  • Neuroscience
  • Psychology
  • Medical Statistics

Background:

  • Dementia classification is challenging without biological markers, especially for early detection and differentiating secondary dementias.
  • Neuropsychological measures offer an empirical approach to distinguish cognitive dysfunction in neurodegenerative diseases.

Purpose of the Study:

  • To develop and validate a statistical classification formula for dementia using neuropsychological tests.
  • To differentiate between Alzheimer's disease (AD) and Huntington's disease (HD) cognitive profiles.
  • To assess the formula's utility in identifying dementia in Parkinson's disease (PD).

Main Methods:

  • Utilized age-scaled neurobehavioral test results (Wechsler Adult Intelligence Scale-Revised, Wechsler Memory Scale) from AD, HD patients, and controls.
  • Employed stepwise discriminant analysis to derive a classification formula.
  • Validated the formula on an independent sample and applied it to PD patients.

Main Results:

  • The formula accurately distinguished controls from demented patients (99%) and separated AD from HD groups (79%).
  • Classification accuracy for dementia was 96% and AD vs. HD was 78% on the validation sample.
  • 38% of PD patients were classified as demented, with 65% showing an HD-like cognitive pattern.

Conclusions:

  • The developed statistical approach effectively classifies dementia and differentiates between AD and HD.
  • The method shows promise for identifying dementia in other neurodegenerative conditions like PD.
  • This empirical strategy aids in dementia classification and subtype discrimination, particularly in complex cases.